Related Experiment Video
Updated: Sep 16, 2025

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
From Combination Early Detection to Multicancer Testing: Shifting Cancer Care toward Proactive Prevention and
Adriana Albini1, Dario Trapani2,3, Francesco Bertolini4
1Scientific Directorate, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy.
Early cancer detection using multi-cancer early detection (MCED) assays and molecular profiling enables proactive prevention strategies. This integrated approach moves beyond single-cancer screening for improved outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Preventive Medicine
Background:
- Early tumor detection and understanding cancer development are crucial for effective prevention.
- Molecular profiling identifies genetic, epigenetic, immune, and microenvironmental alterations linked to cancer risk.
- Liquid biopsy and metagenome analysis offer non-invasive methods for detecting cancer biomarkers and gut microbiota imbalances.
Purpose of the Study:
- To explore advancements in multi-cancer early detection (MCED) assays for proactive cancer interception.
- To highlight the integration of diverse biological signals beyond genomics for comprehensive risk assessment.
- To emphasize the shift towards mechanism-based, multidimensional screening for personalized cancer prevention.
Main Methods:
- Utilizing molecular profiling to detect alterations in genetic, epigenetic, immune, and microenvironmental factors.
- Employing liquid biopsy for non-invasive analysis of circulating tumor cells, nucleic acids, and other biomarkers.
- Integrating data from multiple sources, including metagenome analysis and clonal hematopoiesis of indeterminate potential (CHIP), with artificial intelligence.
Main Results:
- MCED assays capture signals from multiple malignancies in a single blood sample, going beyond genomics to include immune and metabolic shifts.
- Analysis of combined cancer drivers and enablers provides sensitive, personalized measures of cancer prodromic profiles.
- Artificial intelligence aids in integrating diverse data for individualized cancer risk profiling.
Conclusions:
- A multidimensional approach to early detection and interception advances practical clinical goals in cancer prevention.
- Integrated, mechanism-based screening fosters a proactive prevention model, moving beyond single-cancer detection.
- Empowering cancer interception through lifestyle modification, nutritional optimization, and targeted interventions is facilitated by these advanced detection methods.
Related Concept Videos
Preventive Healthcare Services
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Levels of Health Promotion and Illness Prevention
In primary prevention, actions taken before disease onset prevent the disease from...
Cancer Survival Analysis
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

